A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

NCT06943950 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Plaque Psoriasis

Interventions

DRUG: SYHX1901

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.